US OptionsDetailed Quotes
MRNS240517P11000
- 5.40
- 0.000.00%
15min DelayClose May 17 16:00 ET
0.00High0.00Low
5.40Open5.40Pre Close0 Volume0 Open Interest11.00Strike Price0.00Turnover0.00%IV-84.96%PremiumMay 17, 2024Expiry Date9.67Intrinsic Value100Multiplier0DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma0.12Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Marinus Pharmaceuticals Stock Discussion
Sign in to post a comment
$Marinus Pharmaceuticals(MRNS.US$ Topline data from the TrustTSC trial is anticipated in the first half of the fourth quarter of 2024. Marinus is targeting submission of a supplemental New Drug Application to the U.S. Food and Drug Administration in April 2025 with priority review requested.
2
2
$Marinus Pharmaceuticals(MRNS.US$ Marinus Pharmaceuticals Inc: Enrollment Complete in Phase 3 Trusttsc Trial With Topline Data Anticipated in First Half of Q4 2024
$United Therapeutics(UTHR.US$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US$ Phase 3
$Liquidia(LQDA.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$MorphoSys(MOR.US$ Phase 3
$Immunocore(IMCR.US$ Phase 3
$Crinetics(CRNX.US$ Phase 3
$UroGen Pharma Ltd(URGN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$Capricor Therapeutics(CAPR.US$ Phase 3
$Annexon(ANNX.US$ Phase 3
$Lipocine(LPCN.US$ Phase 3...
$Ironwood Pharmaceuticals(IRWD.US$ Phase 3
$Liquidia(LQDA.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$MorphoSys(MOR.US$ Phase 3
$Immunocore(IMCR.US$ Phase 3
$Crinetics(CRNX.US$ Phase 3
$UroGen Pharma Ltd(URGN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$AstraZeneca(AZN.US$ Phase 3
$Capricor Therapeutics(CAPR.US$ Phase 3
$Annexon(ANNX.US$ Phase 3
$Lipocine(LPCN.US$ Phase 3...
10
1
$Travere Therapeutic(TVTX.US$ Phase 3
$CG Oncology(CGON.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$BioCardia(BCDA.US$ Phase 3
$Insmed(INSM.US$ Phase 3
$GlycoMimetics(GLYC.US$ Phase 3
$Annexon(ANNX.US$ Phase 3
$Lipocine(LPCN.US$ Phase 3
$FibroGen(FGEN.US$ Phase 3
$UroGen Pharma Ltd(URGN.US$ Phase 3
$Lyra Therapeutics(LYRA.US$ Phase 3
$Citius Pharmaceuticals(CTXR.US$ Phase 3
$Jaguar Health(JAGX.US$ Phas...
$CG Oncology(CGON.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$United Therapeutics(UTHR.US$ Phase 3
$BioCardia(BCDA.US$ Phase 3
$Insmed(INSM.US$ Phase 3
$GlycoMimetics(GLYC.US$ Phase 3
$Annexon(ANNX.US$ Phase 3
$Lipocine(LPCN.US$ Phase 3
$FibroGen(FGEN.US$ Phase 3
$UroGen Pharma Ltd(URGN.US$ Phase 3
$Lyra Therapeutics(LYRA.US$ Phase 3
$Citius Pharmaceuticals(CTXR.US$ Phase 3
$Jaguar Health(JAGX.US$ Phas...
19
$Marinus Pharmaceuticals(MRNS.US$ IF IT KEEP GOING DOWN THEN HAILO MA CLOSE TO 1 THEN DELETE 🤩🤩🤩
$Marinus Pharmaceuticals(MRNS.US$ I bought the dip now
7
1
No comment yet
STD0313 : what is up with the huge drop from 10 to 1 dollar......MM making room for themselves? Did they file something late.....took a very quick scan and didn't see anything
TrytosaveabitOP STD0313: So this is how I see it! Bad earnings. Hedge funds shorting! Also when you have 50% of the daily volume going off exchange, it keeps a buying pressure of the board that would move price up. Take yesterday! Volume was just over 900K and damn close to 500K of that was routed off exchange! Kinda criminal IMO! There is over 5M shares sold short!